跳至主要内容
临床试验/NCT03392558
NCT03392558已完成不适用

The Suitability of Two Skin Care Regimens in Moderate to Severe Facial Rosacea

Burt's Bees Inc.1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2018年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80
试验地点
1
主要终点
Investigator Global Assessment of Rosacea Scale Score

研究概览

简要总结

This study evaluates a nature-based sensitive skin regimen (NBSSR), as a suitable adjunct topical application to prescription medication when administered daily over the course of four weeks, in moderate to severe rosacea in comparison to the control regimen (CR).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Investigator)

入排标准

年龄范围
25 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Subjects must be female 25-60 years of age with moderate facial rosacea at screening and 6 or 7 papules and/or pustules; as well as, no other known medical conditions that, in the investigator's opinion, may interfere with study participation.
  • •Women of childbearing potential must be willing to use a form of birth control during the study. For the purpose of this study, the following are considered acceptable methods of birth control: oral contraceptives, Norplant(R), Depo-Provera(R) double barrier methods (e.g., condom and spermacide) and abstinence.
  • •Subjects must provide written informed consent.
  • •Willingness to comply with the study design and procedures.
  • •Subjects who agree to sign a photography release form.

排除标准

  • •Any dermatological disorder, except rosacea requiring the use of prescription medication, which in the investigator's opinion, may interfere with the accurate evaluation of the subject's skin characteristics,
  • •Subjects who are using any anti-aging skin care products within 4 weeks of study enrollment.
  • •Subjects who are not willing to use only the assigned study products and nothing else, except for self-selected colored cosmetics that must remain unchanged during the study, to their face.
  • •Subjects who have demonstrated a previous hypersensitivity reaction to any of the ingredients of the study products.
  • •Subjects, who are pregnant, breast feeding, or planning a pregnancy.
  • •Subjects with clinically significant unstable medical disorders.
  • •Subjects who are unwilling or unable to comply with the requirements of the protocol.
  • •Subjects who have history of a psychological illness or condition that would interfere with their ability to understand and follow the requirements of the study.
  • •Subjects who have participated in any clinical study in the past 30 days or are currently participating in any other clinical study.
  • •Subjects with any planned surgeries and/or invasive medical procedures during the course of the study.
  • •Subjects who started hormone replacement therapies (HRT) or hormones for birth control less than 3 months prior to study entry or who plan on starting, stopping, or changing doses of HRT or hormones for birth control during the study.
  • •Subjects who currently or frequently use high doses of anti-inflammatory drugs for a defined medication condition. Aspirin use should not exceed 2 tablets (650 mg) per day.
  • •Subjects currently receiving any anticancer, immunosuppressive treatments/ medications (e.g., azathioprine, belimumab, cyclophosphamide, Enbrel, Imuran, Humira, mycophenolate mofetil, methotrexate, prednisone, Remicade, Stelara.), or radiation as determined by the initial paperwork.
  • •Subjects with a history of immunosuppression/immune deficiency disorders (including (HIV infection or AIDS) or currently using immunosuppressive medications (e.g., azathioprine, belimumab, cyclophosphamide, Enbrel, Imuran, Humira, mycophenolate mofetil, methotrexate, prednisone, Remicade, Stelara.) and/or radiation as determined by study documentation.

研究组 & 干预措施

Nature-Based Sensitive Skin Regimen

Experimental

Burt's Bees Skin Care Regimen (Nature Based Sensitive Skin Regimen, NBSSR):

  1. Burt's Bees Sensitive Facial Cleanser (to be used day and night)
  2. Burt's Bees Sensitive Daily Moisturizing Cream (to be used in the day)
  3. Burt's Bees Sensitive Night Cream (to be used at night)

干预措施: Burt's Bees Skin Care Regimen (Other)

Control Regimen

Active Comparator

Control Skin Care Regimen (Control Regimen, CR):

  1. Cetaphil Gentle Skin Cleanser (to be used day and night)
  2. Cetaphil Moisturizing Lotion (to be used day and night)

干预措施: Control Regimen (Other)

结局指标

主要结局

Investigator Global Assessment of Rosacea Scale Score

时间窗: 4 weeks

The primary efficacy endpoint is no increase in the cumulative Investigator Global Assessment of Rosacea Scale score, measured at Week 4 from baseline

次要结局

  • Overall Skin Quality(4 weeks)

研究者

发起方
Burt's Bees Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验